To enlarge a spectrum of biologically active compounds in the series of the 1,2,4-triazino[5,6-b] [1, 4] benzothiazine (1, 2, 
Introduction. Biological effect of polycyclic planar molecules is commonly ascribed to their interaction with DNA [1] . The compounds of such nature may inhibit the function of enzyme complexes in the system of nucleic acid biosynthesis involving DNA, such as RNA-and DNA-polymerase, -topoisomerase, -helicase complexes, etc. Preliminary studies on the effect of a number of new tricyclic 1,2,4-triazine-bearing bases and their nucleosides on reproduction of viruses from Íårpes viridae family, virus of common herpes (VCH) and Epstein-Barr virus (EBV) [3, 4] prompted us for further optimization of the parent base to obtain more effective antiviral substances.
The aim of this work is to extend the spectrum of effective biologically active compounds of tricyclic system, 1,2,4-triazino [5,6-b] [1, 4] -benzothiazines (1,2,4-TBT), bioisosters of the alloxazine and isoalloxazine (that present natural components of riboflavin coenzymes), and structural analogs of some polycyclic antibiotics. Given the possibility of viral polymerase inhibition it seemed reasonable to estimate the effect of new derivatives on the RNA synthesis in model system of transcription directed by DNA-dependent Ò7 RNA-polymerase (RNAP) in vitro.
To achieve the desired aim it was necessary to tackle such problems: to perform computer design of starting compound, 3-oxo-1,2,4-TBT, through modifying triazine and benzothiazine fragments of the molecule and clear up the putative mechanism of action for the designed new structures by their molecular docking to virtual target of the T7 RNAP catalytic site.
Materials and methods All calculations were performed in program QXP /Flo+ [8] . Docking was carried out using flexible ligand and fixed models of the receptor to employ the algorithm of systematic docking (SDOCK+), which demonstrated satisfactory ability to reproduce ligand conformation with minimal RMSD (medium square deviation) relative to crystallographic results [9] . Maximal number of calculation steps was determined on 300 and 10 optimal complexes (proceeding from inherent scoring functions of QXP) that are maintained for [the] analysis. The receptor model was based on X-ray results for Ò7 RNAP-DNA (PDB X-Ray code: 1SOV) transcription complex [10] .
Chemical synthesis. For the synthesis of condensed triazine derivatives 6-bromo-1,2,4-triazin-3,5(2Í,4Í)-dione (1), its 2-b-D-triacetylribofuranoside (2) and 2-amino-4(5)-R-benzothiols (3) were used, synthesized according to described earlier techniques [11, 12] . Other reagents and solvents were purchased from UkrOrgSynthesis (Ukraine) and "Fluka" (Switzerland).
The obtained compounds were controlled through thin layer chromatography (TLC) on the plates Silica gel 60 F254 («Ìårñk», Germany) in the system of chloroform/ethanol (9:1) or (98:2) solvents. For preparative chromatography on silica gel a gradient of ethanol concentrations in chloroform was used. 1 Í-NMR spectra of synthesized compounds were recorded on spectrometer «Mercury-400» («Varian», USA) in DMSO-d6, electronic absorption spectra -on spectrometer Shimadzu UV-3100 (Japan). Melting points (mp) were estimated on Boetius device.
General technique for production of 2,4-dihydro-3-oxo-7(8)-R-1,2,4-triazino [5,6-b] [1, 4] b enzothiazines (4à-c). 5-mMol triazine bromoderivative (1) and 5 mmîl respective 2-aminobenzothiol (3) were boiled in 10 ml of dioxane-pyridine mixture (9:1) with backflow condenser for 4 h. The first hour reaction results in voluminous precipitate which is gradually dissolved during its further occurrence. Following the reaction mixture cooling, the solvents were removed in vacuum, to crystallize the residue with N,N-dimethylformamide (physico-chemical characteristics of the novel compounds are presented in the table) . [5,6-b] [1, 4] [5,6-b] [1, 4] benzothiazine (5b) was performed similarly to 5a by the both methods. Yield of the target ribonucleoside by the method I made up 42.3 mg (11%), by the method II -87.5 mg (23%) of analytically pure 5b.
Synthesis of 2-b-D-ribofuranosyl-3(4Í)-oxo-7-trifluoromethyl-1,2,4-triazino

Synthesis of 2-b-
Transcription reaction ³n v³trî. The technique for testing the synthesized substances on [a] model system of transcription was presented in previous report [13] . There were used such reagents: linearized DNA of pTZ19R plasmide as a template, four canonical ribonucleoside triphosphates, RNA inhibitor (RiboLock), transcription buffer (tris-HCl, pH 7.5, MgCl 2 , spermidine, dithiothreitol) of the firm "Fermentas" (Lithuania).
Test-agent pre-incubation with DNA-template or RNA-polymerase was conducted in the presence of other system components during 15 min at room temperature. Following pre-incubation the system was added with proper lacking biopolymer, and the reaction proceeded for 40 min.
Results and discussion. Molecular modeling of condensed triazines. Through computer studies it was scheduled to solve such tasks: determine the topology and tautomere status of the 3-oxo-1,2,4-TBT parent base, accomplish the design by introducing the substituents of various structure and nature in triazine and benzothiazine fragments of molecule; elucidate behavior of the basic molecule and its derivatives in the model of Ò7 RNAÐ binding site; construct more active derivatives of the basic structure consistent with numerical trials.
Constructing the novel molecular structures suggests the invariance of the functional group position, donor-acceptor centers in triazine 1,2,4-ÒBÒ fragment, capable to interact with both matrix bases and conservative amino acid surrounding. Benzothiazine fragment being linked to triazine nucleus fills the extended cleft of polymerase catalytic site concurrently promoting realization of the numerous possibilities for stackingand cation-p-interaction. To our mind substitution of the benzene nucleus may enhance the interaction of new derivatives with the enzyme at the expense of increase in their volume and hydrophobicity.
The presence of four nitrogen atoms and mobile protons results in tautomeric conversions of the basic compound and its derivatives. [5,6-b] [1, 4] benzothiazine derivatives(4à-ñ, 5à, 5b)
The first step of the computer studies was to determine more possible and energetically more advantageous tautomers of basic 3-oxo-1,2,4-TBT and their topology. Above characteristics may reflect in their behavior in the enzyme target and, hence, in the mechanism of action of these compounds, in other words, may affect their interaction with biopolymeres. The variations in energy of such interaction for a number of tautomers appeared to be insignificant while amino acid surrounding tended to be cardinally different, sometimes provoking emergence of so called "false positive hits". Optimization of the 3-oxo-1,2,4-TBT structure was accomplished by DFT.
The spatial structures of the most probable tautomers of basic compound were constructed by means of molecular design. Only one of three tautomers structures was close to planar, which appears to be energetically most favorable. According to spectral results exactly this tautomer was realized upon synthesis and used in docking to study the interaction between the compounds investigated and Ò7 RNAP active site. Fig.1 presents the structures of 3-oxo-1,2,4-TBT tautomers (4) .
Further design of 3-oxo-1,2,4-TBT was aimed at enhancing the interaction of novel derivatives with the enzyme target and determining the putative mechanism of their interaction. To fill the volume of the enzyme complex pocket more densely the benzothiazine fragment was modified by introducing the haloid, haloidalkyl and alkyl groups in various positions.
While constructing the model of active site we considered all amino acid residues within the radius of 0.1 nm around the catalytic pocket as those that may be involved in ligand binding and those that ensure polymerase functioning (Fig. 2) . It is important to define the enzyme dynamics during the catalytic event.
It is necessary in order to avoid the appearance of the above mentioned "false positive hits", i.e. the compounds which should be active according to calculations but do not show any activity in biotestng. Through the docking in the chosen region of transcription complex in the model of Ò7 RNAP site there was carried out the virtual screening for modelled structures. The analysis of the obtained data revealed that ligands were situated for certain in the catalytic pocket and kept in it at the expense of hydrogen bonds, stacking-and cation-p-interaction with amino acid residues and matrix (template) nucleotide bases. The triazine fragment for most of considered structures is localized within immediate proximity to the catalytic Mg 2+ ion and Tyr639 residue which takes part in recognition of the regular ribonucleoside triphosphate involved in the catalytic site. (Fig. 3, see pasting- 
in).
For derivatives with substitutes in the benzene ring two various models of binding proved to be acceptable. between respective atoms makes up 0.23 and 0.20 nm) with substitutes establishing slight electrostatic bind with Lys441 (Fig. 4 , see pasting-in).
There is other situation for 3-Oxo-1,2,4-TBT: the triazine fragment is kept in the active site owing to hydrogen bonds with residues Arg422 and Tyr427 (the distance between the atoms comprises 0.28 and 0.21 nm, respectively), while benzothiazine one -due to hydrogen bonds with His784 residue (the distance between the proper atoms is 0.10 nm). Alkyl strand seems to be plunged into the bulky pocket, formed by the Ñys540 and Met635 residues (Fig. 5 , see pasting-in) and fixed in it by the hydrophobic interactions. In such case the compound bonds with the matrix base within the complex are lacking, hence, its retention does occur only due to the interaction with enzyme.
Analysis of behaviour of the above mentioned bases' derivatives that carry glycoside residue in the triazine fragment in the model of catalytic site demonstrated the lack of unambiguous superposition upon identification of the most advantageous versions of their arrangement within the target. It should be emphasized that significant distinctions in the respective positions of the molecule in a virtual target may indicate a low energy of binding and as a result low inhibitory capacity of this substance despite the presence of five hydrogen bonds (Tyr639, His784, Asp812 Lys441, Mg
2+
) and minor distances between the atoms which form them (0.16; 0.22; 0.29; 0.26 ànd 0.25, respectively).
The results of virtual screening allow us to suggest that the considered compounds may be potential inhibitors, the extended alkyl substitute of benzothiazine fragment being able to increase complex stability and in this way enhance their inhibitory activity. On the contrary, introduction of glycoside residue into the triazine fragment may result in an opposite effect.
Confirmation or rejection of this working hypothesis may come from testing the derived compounds' activity in the in vitro system of transcription catalysed by Ò7 RNAP.
In earlier studies we proposed rather simple scheme for the synthesis of tricyclic triazine-bearing system and its functionalization [3, 4] . Just this approach was extended to the synthesis of a number of new derivatives of basic 3-oxo-1,2,4-TBT (4). Manufacturability and effectiveness are the positive attributes of the above method -the reaction occurs in unistage manner in the absence of specific conditions, thus allowing production in preparative quantities.
Such approach was used to obtain new triazine-bearing bases, substituted for chlorine atom or trifluoromethyl group at 7 or n-butyl substituent at 8 position of the benzothiazine fragment (4à-ñ) and respective ribonucleosides 5à, 5b with sugar moiety at position 2 of the triazine fragment.
The efficiency of synthesis appeared to be over 50 %, reaching for 4à 67 %, 4b -80%, 4c -53 %, but lower than that for non-substituted 3-oxo-1,2,4-TBT yielded up to 90%. These data undoubtedly suggest the essential effect of the chemical nature of the substituents in the 2-aminobenzothiol molecule on the process of triazine-bearing heterosystem formation. As evidenced from Fig. 6 , ribonucleosides 5à and 5b were obtained by two techniques to define which of them is more productive. In the case of triacetylriboside 5-bromo-6-azauracil (2) interaction with 2-aminobenzothiol 3a under above conditions (Fig. 6 ) the yield of the target product was 27%, while upon using reagent 3b it is essentially less -11% (compound 5b). Considerable decrease in the efficiency of synthesis of the ribofuranosides by this method may be ascribed first of all to acylnucleoside susceptibility (2) to the reaction conditions (temperature over 100°C), and, like upon bases synthesis , to rather considerable influence of Cl-and CF 3 -substitutes of corresponding 2-aminobenzothiols.
Direct glycosylation of the triazine-bearing bases (4à, 4b) by the described procedure [3] somewhat increased a yield of the final product for [the] ÑF 3 -substituted [basis] (33%) and significantly raised outcome for the Cl-substituted base (23%). Negative contribution to the glycosylation process and obtainng nucleoside of needed structure is determined by the presence of at least two reaction centres (nitrogen atoms in positions 2 and 4), i.e there is a possibility of formation of two isomeric products. Analysis of the reaction mixture showed that total yield of acylated glycosides was about 60%, but the proportion of acetate of the prevailing 2-N-nucleoside did not exceed 45%. Free ribofuranosides 5à, 5b were derived by deacetylation of corresponding acetates with aqua-alcohol solution of ammonium hydroxide.
The comparison of tricyclic ribonucleosides preparations, obtained in alternative ways, showed their identity.
Investigation of the regulatory properties of the obtained compounds in the model transcription complex in vitro. The primary base (4) and its ribofuranoside derivative (5) as compounds for comparison, the synthesized bases (4à-ñ) and two ribonucleosides (5à, 5b) were tested in the enzyme system. The concentration-and structure-dependent inhibition of total RNA synthesis by the 1.2.4-ÒBÒ derivatives was observed in the model system of Ò7 RNAP transcription in vitro . Contrary to the initial base 4 , RNA synthesis was reliably suppressed by three bases -with Ñ1-, CF 3 -and n-butyl-substitutes in the benzothiazine fragment of compounds 4à, 4b and 4ñ (Fig. 7) . The n-butyl derivative 4c proved to be the most effective inhibitor of the transcription process in vitro among the compounds under study as was predicted by the docking results. Practically complete absence of the transcript was found at 4c concentration of 6 mg/ml.
Our hypothesis concerning glycoside derivatives 5à and 5b was also affirmed. Their testing in "living" enzyme system did not reveal any inhibition of RNA synthesis as compared with the corresponding bases, i.e. these ribonucleosides (5à, 5b) appeared to be "erroneously found hits" as was predicted by the results of docking.
To establish to which of two biopolymers, DNA and Ò7 RNAP, the 1.2.4-ÒBÒ derivatives possess higher affinity the compounds were pre-incubated with each of them. As is exemplified from butyl 4c derivative, the pre-incubation with Ò7 RNAP practically did not change the course of concentration-dependent transcription reaction, as compared with the standard conditions, but almost half reduced the minimal inhibiting concentration of this substance (Fig. 8) . Instead, pre-incubation of 4c with DNA considerably affects the course of concentration-dependent RNA synthesis. The substance distribution along the template seems to reduce substantially the inhibitor working concentration and as a result RNA transcript appears at its higher concentrations (starting from 25 mg/ml). 2) The compounds of predicted structure with lateral substituents in positions 2, 7 and 8 in 3-oxo-1,2,4-triazino [5,6-b] [1, 4] benzothiazine were synthesized using technologically advantageous methods, among them 2-N-ribonucleosides with CF 3 -group or chlorine atom in the benzene ring; the identity of the glycoside derivatives obtained by two independent methods was verified.
3) Rather effective inhibitors of RNA synthesis were identified by testing the synthesized substances in Ò7 RNAÐ transcription system in vitro . Analysis of the results allowed us to suggest that the compounds studied are able to interact with both biopolymers, the enzyme and DNA. According to the biological test, 3-oxo-8-n-butyl-triazinobenzothiazine appeared to be 
